Showing results (71-80 of 1,318) with videos related to
Sort By:
Pageof 132
Expert Opinion on Drug Metabolism & Toxicology|November 11, 2024
Clinical pharmacokinetics of levodopa and relevant add-on therapies for Parkinson's diseaseThomas MüllerExpert Opinion on Pharmacotherapy|October 15, 2024
Evaluating pimavanserin tartrate as a treatment in Parkinson's diseaseThomas MüllerNeurodegenerative Disease Management|December 17, 2021
GOCOVRI® (amantadine) extended-release capsules in Parkinson's diseaseThomas MüllerMedizinhistorisches Journal|July 1, 2004
[Comparison and transfer analysis in the History of Medicine? A discussion using travelelogues as a source]Thomas MüllerGesnerus|March 20, 2004
[From Basel to Bad Nassau. The fate of the psychoanalyst Arthur Muthmann (1875-1957)]Thomas MüllerPatient Preference and Adherence|November 26, 2009
Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preferenceThomas MüllerExpert Opinion on Pharmacotherapy|August 30, 2017
Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's diseaseThomas MüllerExpert Opinion on Investigational Drugs|July 22, 2010
New small molecules for the treatment of Parkinson's diseaseThomas MüllerExpert Opinion on Drug Metabolism & Toxicology|May 7, 2013
Suitability of the adenosine antagonist istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerationsThomas MüllerExpert Review of Neurotherapeutics|September 24, 2013
Current status of safinamide for the drug portfolio of Parkinson's disease therapyThomas MüllerPageof 132